Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02763254
Title Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas (CIVIC)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cell Medica Ltd
Indications

Hodgkin's lymphoma

diffuse large B-cell lymphoma

Therapies

CMD-003

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.